Major Highlights for Month of June 2015:
...................................................................
Indian Pharma Market (IPM) clocked 7928 Crs in June 2015
........................................................................
IPM grew at 14.8% for the month of June 2015
...................................................................................
Companies:
For the month of June 2015, among the top 10, Sun* grew by 27.9% followed by Pfizer at 20.2% & Abbott* at 19.0%
.........................................................................................................
23 companies crossed the growth of IPM for the month of June 2015 among top 50
...............................................................................................
Among the top 50, Wockhardt has the highest growth of 36.2% followed by AstraZeneca at 35.4% & Glenmark at 34.5 %
..................................................................................................
27 Co's showed growths more than 10% among the top 50
............................................................................................
Among the 11-20 ranked, Glenmark has the highest growth of 34.5% followed by Torrent at 28.3% & USV at 27.1%
..................................................................................................
Among the 21-30 ranked, Wockhardt has the highest growth at 36.2% followed by MSD* 31.6% & Unichem at 20.5% & Novo Nordisk at 18.9%
......................................................................................................
Among the 31-40 ranked, AstraZeneca has the highest growth at 35.4% followed by Akumentis at 33.4% & JBCPL at 27.0%
....................................................................................................
Among the 41-50 ranked, Hetero has the highest growth at 21.0% followed by Fourrts at 17.9% & Allergan at 17.8%
..............................................................................................
Among the 51-60 ranked, Boehringer grew at 79.1% followed by Eli Lilly at 39.9% & Troikaa at 38.4%
..............................................................................................
Among the 61-70 ranked, Fresenius Kabi grew at 38.8% followed by RPG at by 36.1% followed by TTK at 26.3%
..............................................
AstraZeneca enters the 500 Cr Club, Hetero 400 Crs, Troikaa 300 Crs, Tablets India 200 Crs on MAT Basis
8. Dataset : PharmaTrac MAT JUNE 2015 (Val in Crs)(Val in Crs)
77.37%
22.63%
INDIAN MNC
0 2000 4000 6000
ABBOTT*,
5623
GSK, 3075
PFIZER*,
2699
SANOFI
INDIA,
2265
NOVARTIS
, 1179
0200040006000800010000
SUN*, 8058
CIPLA, 4528
ZYDUS*,
3744
MANKIND,
3227
ALKEM*,
3163
GR VAL : 14.4 GR VAL : 13.8
INDIAN/MNC SPLIT: Indian Companies dominate & are growing
above the MarketâŠ
9. Dataset : PharmaTrac MAT JUNE 2015 (Val in Crs)(Val in Crs)
* Abbott + Abbott HC + Novo; Alkem + Indchemie + Cachet; Pfizer + Wyeth; Zydus + Biochem; Micro + Bal
MAT VAL JUN 15
ZONE MAT VAL MS MS (G / L) GR INCRE VAL
IPM 90085 100.00% 0.00% 14.3 11258
SOUTH ZONE 24218 26.88% -0.22% 13.3 2850
NORTH ZONE 23329 25.90% -0.26% 13.1 2707
WEST ZONE 20943 23.25% 0.05% 14.5 2656
EAST ZONE 18363 20.38% 0.30% 16.0 2532
ALL INDIA ONLY 3233 3.59% 0.14% 18.8 513
28%
27%
24%
21%
Jun-14
28%
27%
24%
21%
Jun-15
ZONAL SPLIT: South dominatesâŠWest grows fastâŠ
10. Dataset : PharmaTrac MAT JUNE 2015 (Val in Crs)(Val in Crs)
THERAPY SPLIT: Anti Infectives leads & Gastro Intestinal grows fast
with along with Anti-diabeticsâŠâŠâŠâŠ..